Suchergebnisse - "*Ritonavir"

PubPharm (86)

61

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT) : 96-week results

enthalten in: BMC infectious diseases | 2013

von Kumar, P. | DeJesus, E. | Huhn, G. | +10

62

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results

enthalten in: BMC infectious diseases | 2013

von Kumar, P. | DeJesus, E. | Huhn, G. | +9

63

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results

enthalten in: BMC infectious diseases | 2013

von Kumar, P. | DeJesus, E. | Huhn, G. | +9

64

Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding : the PROMISE-PEP trial Protocol ANRS 12174

enthalten in: BMC infectious diseases | 2012

von Nagot, N. | Kankasa, C. | Meda, N. | +9

65

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV : experience in a pediatric population

enthalten in: BMC infectious diseases | 2012

von Rusconi, S. | Giacomet, V. | Mameli, C. | +5

66

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

enthalten in: BMC infectious diseases | 2012

von Rusconi, S. | Giacomet, V. | Mameli, C. | +5

67

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

enthalten in: BMC infectious diseases | 2012

von Rusconi, S. | Giacomet, V. | Mameli, C. | +5

68

Effect of nanoencapsulation on the phenomenon of drug interaction between anti-M.avium drug, rifabutin and anti-HIV drug, ritonavir by employing poly (lactide-co-glycolide) nanoparticles

enthalten in: BMC infectious diseases | 2012

von Grewal, T. | Sharma, S.

69

Effect of nanoencapsulation on the phenomenon of drug interaction between anti-M.avium drug, rifabutin and anti-HIV drug, ritonavir by employing poly (lactide-co-glycolide) nanoparticles

enthalten in: BMC infectious diseases | 2012

von Grewal, T. | Sharma, S.

70

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease

enthalten in: BMC infectious diseases | 2011

von Esposito, A. | Floridia, M. | d'Ettorre, G. | +7